# ARS Pharmaceuticals, Inc.: Form 10-Q/A for the period ended Sep 30, 2024

- Company: [ARS Pharmaceuticals, Inc.](/companies/spry.md) (CIK 1671858)
- Form: 10-Q/A
- Filed: 2024-12-06
- Accepted by EDGAR: Dec 6, 2024, 16:05 ET
- Period: 2024-09-30
- Accession: 0001193125-24-272445
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1671858/000119312524272445/d864210d10qa.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1671858/000119312524272445/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1671858/000119312524272445/d864210d10qa.htm

Filed Dec 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-272445. Last ingested by Listed: Nov 10, 2026, 04:18 ET. No prices; not investment advice.